Vivani Medical Appoints Finance Veteran August Moretti, Dr. Dean Baker Retires
VANI•Vivani Medical appointed August J. Moretti to its board, naming him Audit Committee chair and Compensation Committee member to support NPM-139 semaglutide implant’s clinical development. Dr. Dean Baker retired after guiding the merger of Nano Precision Medical and Second Sight and chairing both audit and compensation committees.
1. Vivani Medical Appoints August J. Moretti
Vivani Medical appointed industry veteran August J. Moretti to its board of directors, where he will chair the Audit Committee and serve on the Compensation Committee. Moretti’s CFO roles at 4D Molecular Therapeutics, Assertio Therapeutics and Alexza Pharmaceuticals and legal background at Heller Ehrman position him to strengthen financial governance as the company scales.
2. Dr. Dean Baker Retires After Distinguished Service
Dr. Dean Baker retired from Vivani’s board after serving as chair of both the Audit and Compensation Committees and guiding the merger of Nano Precision Medical and Second Sight Medical. Baker’s senior leadership roles at Northrop Grumman, Advanced Bionics and the Alfred E. Mann Institute contributed critical technical and operational insights during Vivani’s formative stages.
3. Governance Role Supports NPM-139 Clinical Program
Moretti’s appointment aligns with Vivani’s progression of its lead semaglutide implant candidate, NPM-139, into clinical trials, leveraging his operating and financial expertise to oversee resource allocation and risk management. The board refresh aims to bolster oversight as the company advances its NanoPortal™ platform toward commercial development for chronic disease treatments.
